Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.54 |
| ▸ | PPARA | Q07869 | 8/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4322251 | 1.00 | PPARG (0.54) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL2952466 | 1.00 | PPARG (0.54) | PPARGPPARALMNAL3MBTL1KMT2A | |
| Water SCHEMBL9256164 | 0.98 | PPARG (0.53) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL1714102 | 0.88 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL338001 | 0.88 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL541965 | 0.88 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL1714197 | 0.88 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| SCHEMBL375933 | 0.88 | PPARG (0.51) | PPARGPPARALMNAL3MBTL1KMT2A | |
| Water SCHEMBL3347709 | 0.86 | PPARG (0.50) | PPARGPPARALMNAL3MBTL1KMT2A | |
| Water SCHEMBL2789432 | 0.86 | PPARG (0.50) | PPARGPPARALMNAL3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4479546-A2 | PROCESSES FOR PREPARATION OF AVACOPAN AND INTERMEDIATES THEREOF | Teva Pharmaceuticals International GmbH (CH) | 2024-12-25 | — | — | EP | claimed |
| WO-2023158722-A2 | PROCESSES FOR PREPARATION OF AVACOPAN AND INTERMEDIATES THEREOF | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2023-08-24 | — | — | WO | claimed |
| CN-110452258-A | A kind of preparation method of dipeptides valine Boroproline salt | BALMXY PHARMACEUTIC CO LTD | 2019-11-15 | — | — | CN | claimed |
| CN-106543119-B | Preparation method of optically pure tasimelteon | 浙江工业大学 | 2019-07-26 | — | — | CN | claimed |
| CN-109988083-A | The preparation method of high-optical-purity escitalopram oxalate intermediate S configuration glycol | 北京哈三联科技有限责任公司 | 2019-07-09 | — | — | CN | claimed |
| CN-106831538-B | The preparation method of tropsch imatinib intermediate | 苏州楚凯药业有限公司 | 2019-06-25 | — | — | CN | claimed |
| CN-108440388-B | The preparation method of one kind (S) -4- ((the bromo- 6- fluorophenyl of 2-) hydroxymethyl) piperidines -1- t-butyl formate | 上海再启生物技术有限公司 | 2019-06-11 | — | — | CN | claimed |
| CN-109810047-A | (R) synthetic method of the chiral intermediate of -3- Phenylpiperidine or/and (S) -3- Phenylpiperidine and Ni Lapani | 上海博邦医药科技有限公司 | 2019-05-28 | — | — | CN | claimed |
| CN-106432199-B | A kind of preparation process of optical voidness Ondansetron and its salt derivative | 南昌市博泽康医药科技有限公司 | 2019-04-26 | — | — | CN | claimed |
| CN-109207088-A | A kind of preparation method of the photosensitive adhesive of PTC function | 合肥萃励新材料科技有限公司 | 2019-01-15 | — | — | CN | claimed |
| CN-104974056-B | Chiral resolution method for preparing high-purity intermediate of trabectedin | 上海皓元生物医药科技有限公司 | 2017-01-11 | — | — | CN | claimed |
| CN-105693605-A | Asymmetric synthesis method of optically pure (R)/(S)-chloroquine | 西安科技大学 | 2016-06-22 | — | — | CN | claimed |
| CN-105693606-A | Asymmetric synthesis method of optically pure (R)/(S)-hydroxychloroquine | 西安科技大学 | 2016-06-22 | — | — | CN | claimed |
| WO-2015063795-A2 | NOVEL PROCESS FOR PREPARATION OF OPTICALLY PURE NOREPHEDRINE AND ITS DERIVATIVES | LAURUS LABS PRIVATE LIMITED (IN) | 2015-05-07 | — | — | WO | claimed |
| EP-2231582-B1 | PROCESS FOR THE SYNTHESIS OF PROPARGYLATED AMINOINDAN DERIVATIVES | CIPLA LTD (IN) | 2011-06-22 | — | — | EP | claimed |
| EP-2231582-A1 | PROCESS FOR THE SYNTHESIS OF PROPARGYLATED AMINOINDAN DERIVATIVES | Cipla Limited (IN) | 2010-09-29 | — | — | EP | claimed |
| WO-2009147687-A2 | AN IMPROVED PROCESS FOR THE SEPARATION OF ENANTIOMERICALLY PURE COMPOUNDS | SHODHANA LABORATORIES LIMITED (IN) | 2009-12-10 | — | — | WO | claimed |
| WO-2009081148-A1 | PROCESS FOR THE SYNTHESIS OF PROPARGYLATED AMINOINDAN DERIVATIVES | CIPLA LIMITED (IN) | 2009-07-02 | — | — | WO | claimed |
| US-7501511-B2 | Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome | MERCK PATENT GMBH (DE) | 2009-03-10 | — | — | US | claimed |
| WO-2009019719-A2 | PROCESS FOR THE PREPARATION OF 3-ARYLOXY-3-ARYLPROPANAMINES | IND-SWIFT LABORATORIES LIMITED (IN) | 2009-02-12 | — | — | WO | claimed |